175 related articles for article (PubMed ID: 20890431)
1. Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Kwon YS; Chi SY; Shin HJ; Kim EY; Yoon BK; Ban HJ; Oh IJ; Kim KS; Kim YC; Lim SC
J Korean Med Sci; 2010 Oct; 25(10):1487-91. PubMed ID: 20890431
[TBL] [Abstract][Full Text] [Related]
2. The prognosis value of C-reactive protein and endothelin-1 in chronic obstructive pulmonary disease patients with pulmonary artery pressure.
Yan F; Pidayi M; Xia Y; Hu X; Yang Z
Pak J Pharm Sci; 2019 Jul; 32(4):1697-1701. PubMed ID: 31608892
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Jiang YW; Pang L; Fang QH; Ma YM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Xie X; Wang X; Zhang Y; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
[TBL] [Abstract][Full Text] [Related]
6. Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
Yang D; Wang L; Jiang P; Kang R; Xie Y
J Healthc Eng; 2022; 2022():3247807. PubMed ID: 35186226
[TBL] [Abstract][Full Text] [Related]
7. Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Bacakoğlu F; Atasever A; Ozhan MH; Gurgun C; Ozkilic H; Guzelant A
Respiration; 2003; 70(6):594-9. PubMed ID: 14732789
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study.
Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A
Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368
[TBL] [Abstract][Full Text] [Related]
9. Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Celik G; Karabiyikoğlu G
Respiration; 1998; 65(4):289-94. PubMed ID: 9730795
[TBL] [Abstract][Full Text] [Related]
10. [The effect of O2 therapy on mixed venous concentration of endothelin-1 in chronic obstructive pulmonary disease].
Nakanishi M; Okamura S; Demura Y; Ishizaki T; Miyamori I
Nihon Kokyuki Gakkai Zasshi; 2001 Oct; 39(10):721-5. PubMed ID: 11828724
[TBL] [Abstract][Full Text] [Related]
11. COPD and cardiac death: pressure (NT-proBNP), inflammation (CRP) or both?
Colice GL
Respiration; 2010; 79(5):353-4. PubMed ID: 20110653
[No Abstract] [Full Text] [Related]
12. Plasma endothelin-1 and nitric oxide correlate with ligustrazine alleviation of pulmonary artery hypertension in patients of chronic cor pulmonale from high altitude plateau during acute exacerbation.
Feng EZ; Yang SY; Huang NX; Yin H; Zhang Y; Tian ZX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):532-7. PubMed ID: 26016363
[TBL] [Abstract][Full Text] [Related]
13. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.
Carratù P; Ventura VA; Maniscalco M; Dragonieri S; Berardi S; Ria R; Quaranta VN; Vacca A; Devito F; Ciccone MM; Phillips BA; Resta O
Sleep Breath; 2016 May; 20(2):613-9. PubMed ID: 26385777
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
[TBL] [Abstract][Full Text] [Related]
16. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension.
Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP
Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853
[TBL] [Abstract][Full Text] [Related]
17. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension.
Carratu P; Scoditti C; Maniscalco M; Seccia TM; Di Gioia G; Gadaleta F; Cardone RA; Dragonieri S; Pierucci P; Spanevello A; Resta O
BMC Pulm Med; 2008 Sep; 8():20. PubMed ID: 18822124
[TBL] [Abstract][Full Text] [Related]
18. [Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic obstructive pulmonary disease].
Tseĭmakh IIa; Momot AP; Kostiuchenko GI; Mamaev AN; Filonova IuA; Kornilova TA; Chuchalin AG
Ter Arkh; 2013; 85(3):17-22. PubMed ID: 23720837
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum γ-glutamyltransferase levels and acute exacerbation of chronic obstructive pulmonary disease.
Ermis H; Celik MR; Gulbas G; Tavli D; Aytemur ZA
Pol Arch Med Wewn; 2013; 123(3):85-90. PubMed ID: 23344614
[TBL] [Abstract][Full Text] [Related]
20. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
